Could a 6-Day steroid taper cut pain and opioid use after knee surgery?

NCT ID NCT05859269

Completed Symptom relief Sponsor: Emory University Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tested whether a 6-day course of oral methylprednisolone (a steroid) after total knee replacement can reduce pain, nausea, and the need for opioid painkillers. 101 adults with knee arthritis were randomly assigned to receive either the steroid taper or standard care. The goal is to improve early recovery after a common but painful surgery.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Methylprednisolone (Medrol Dose Pak)
What this could lead to: If it works, this could provide a simple, short-term way to reduce pain and nausea after knee replacement, helping patients recover more comfortably.
What could go wrong: This is a small, completed Phase 4 trial with 101 participants. The steroid taper may not significantly improve outcomes over standard care, and steroids carry risks like infection or blood sugar changes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for KNEE ARTHRITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

osteoarthritis, knee

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

KNEE ARTHRITIS

Contacts and locations

Locations

Emory Musculoskeletal Institute

Atlanta, Georgia, 30329, United States
Emory University Orthopaedics & Spine Hospital

Tucker, Georgia, 30084, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.